Compare WING & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WING | SHC |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.0B |
| IPO Year | 2015 | 2020 |
| Metric | WING | SHC |
|---|---|---|
| Price | $135.20 | $17.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 27 | 7 |
| Target Price | ★ $295.92 | $20.33 |
| AVG Volume (30 Days) | 1.0M | ★ 2.8M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | 67.84 | ★ 68.75 |
| EPS | ★ 1.08 | 0.09 |
| Revenue | $696,853,000.00 | ★ $1,163,617,000.00 |
| Revenue This Year | $17.20 | $7.51 |
| Revenue Next Year | $15.86 | $6.00 |
| P/E Ratio | ★ $125.45 | $194.33 |
| Revenue Growth | ★ 11.35 | 5.74 |
| 52 Week Low | $116.35 | $11.00 |
| 52 Week High | $381.45 | $19.85 |
| Indicator | WING | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 37.70 | 54.45 |
| Support Level | $116.35 | $15.11 |
| Resistance Level | $176.24 | $17.80 |
| Average True Range (ATR) | 8.42 | 0.52 |
| MACD | -2.54 | -0.13 |
| Stochastic Oscillator | 8.94 | 46.80 |
Wingstop is a fast casual restaurant concept built around a simple chicken-centric menu. The firm primarily offers bone-in and boneless wings, tenders, and a chicken sandwich, customizable across 12 flavors. The banner generated $5.3 billion in system sales in 2025 across 3,056 units, with 85% located in the US. Wingstop largely operates as a franchisor, with 98% of units franchised, and earns revenue largely from collecting royalties and advertising fees paid by franchisees, with a smaller contribution from company-owned restaurant sales.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.